Management of Hypoglycemia During PET-CT Preparation
Blood Glucose Monitoring Requirements
- The European Journal of Nuclear Medicine and Molecular Imaging recommends checking blood glucose upon patient arrival at the imaging center to identify levels that are too low (below 4 mmol/L or 70 mg/dL) or too high, avoiding unnecessary waiting time 1, 3, 4, 5
- A calibrated glucometer or bedside glucose measurement device should be used for screening purposes 1, 6
- Blood glucose must be measured again immediately prior to FDG administration 1, 3, 4
Immediate Treatment Protocol for Hypoglycemia
- For conscious patients who can swallow, administer 15-20 grams of oral glucose in the form of dextrose tablets as first-line treatment, and recheck blood glucose every 15 minutes, repeating treatment until glucose returns to ≥70 mg/dL 2, 7
- If dextrose tablets are not available, alternatives containing at least 15 grams of simple sugars can be used, such as 1 tablespoon table sugar, 6-8 oz apple or orange juice, 6-8 oz regular soda, 1 tablespoon honey, or 15-25 jellybeans, gummy bears, or hard-shelled candies 2
Timing Considerations for PET-CT Scanning
- Delay FDG injection until blood glucose is ≥4 mmol/L (70 mg/dL) to ensure adequate scan quality and patient safety 1, 3, 4, 5
- The upper acceptable limit for clinical PET-CT is <11 mmol/L (200 mg/dL) 1, 3, 4
Special Considerations for Diabetic Patients
- For patients with type 1 diabetes, continue prescribed daily insulin doses when consuming meals, avoid short-acting insulin 4-6 hours before the study, and use sliding-scale insulin during meal preparation but avoid it on the day of the study 8, 5
- For patients with type 2 diabetes, stop oral hypoglycemic medications during the fasting period, hold the morning dose, and avoid taking insulin 4-6 hours before the study 7, 8
Critical Pitfalls to Avoid
- Never proceed with FDG injection when glucose is <4 mmol/L (70 mg/dL), as this compromises both patient safety and scan quality 1, 3, 4, 5
- Avoid administering insulin to correct hyperglycemia without adequate monitoring, as this may precipitate hypoglycemia 8